Market Vectors Biotech ETF is an open-end management investment company. The Fund seeks to replicate the price and yield performance of the Market Vectors U.S. Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include small- and medium-capitalization companies and foreign companies that are listed on a U.S. exchange. As of Sept 30 2013, the Fund's total assets were $435,917,620 and its investment portfolio was valued at $434,447,714. We show 123 historical shares outstanding datapoints in our BBH shares outstanding history coverage, used to compute BBH market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BBH market cap history over the course of time is important for investors
interested in comparing BBH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BBH versus a peer is one thing; comparing
BBH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BBH can fluctuate over the course of history.
With this page we aim to empower investors researching BBH by allowing them to research the BBH market cap history. |
Free BBH Email Alerts:
Video: The Importance of Market Cap
